Biopsy of Soft Tissue Tumors
Although the choice of biopsy type largely depends on the particular clinical setting and the experience of the team, core needle biopsy (CBN) is recommended as the first-choice procedure for obtaining representative specimens of soft tissue tumors for histologic and immunohistochemical examination. It allows one-surgery or neoadjuvant chemotherapy planning when combined with appropriate imaging. It can be performed under (PET)–CT or ultrasound guidance, CT being preferred for deep-seated lesions or those that are difficult to reach. The entry point and the pathway are determined in cross talk with the managing surgeon. Tissue sample fixation is adapted to permit immunohistochemical characterization.
KeywordsSoft Tissue Sarcoma Core Needle Biopsy Soft Tissue Tumor Surgical Biopsy Soft Tissue Lesion
- 6.Bickels J, Jelinek JS, Shmookler BM, Neff RS, Malawer MM (1999) Biopsy of musculoskeletal tumors. Current concepts. Clin Orthop (368):212–219Google Scholar
- 11.Gangi A, Guth S, Dietemann J-L, Roy C (2001) Interventional Musculoskeletal Procedures Radiographics 21: E1-e1 (online only)Google Scholar
- 12.Gielen JLMA, De Schepper AM, Ceyssens S, Creytens DH, Somville J,Van Dyck P, Pauwels P, Peeters M, Parizel PM (2013) Comparison of efficacy of surgical-, CT- and PET-CT-guided biopsy in musculoskeletal lesions. Insights Imaging, 4, supplement 1, Conference Abstract ECR B-0732Google Scholar
- 17.Hogendoorn PCW, Collin F, Daugaard S, Dei Tos PA, Fisher C, Schneider U, Sciot R, pathology and biology subcommittee of the EORTC Soft Tissue and Bone Sarcoma Group (2004) Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment. Eur J Cancer 40(11):1644–1654CrossRefPubMedGoogle Scholar